BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29246200)

  • 21. Clinical and molecular characterization in a cohort of patients with progressive pseudorheumatoid dysplasia.
    El Dessouki D; Amr K; Kholoussi N; Rady HM; Temtamy SA; Abdou MMS; Aglan M
    Am J Med Genet A; 2023 Sep; 191(9):2329-2336. PubMed ID: 37377052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association analysis on polymorphisms in WISP3 gene and developmental dysplasia of the hip in Han Chinese population: A case-control study.
    Zhang J; Yan M; Zhang Y; Yang H; Sun Y
    Gene; 2018 Jul; 664():192-195. PubMed ID: 29680248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Skeletal phenotype/genotype in progressive pseudorheumatoid chondrodysplasia.
    Al Kaissi A; Kenis V; Jemaa LB; Sassi H; Shboul M; Grill F; Ganger R; Kircher SG
    Clin Rheumatol; 2020 Feb; 39(2):553-560. PubMed ID: 31628567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delayed-onset progressive pseudorheumatoid dysplasia with secondary synovial chondromatosis.
    Shahi P; Sehgal A; Sudan A; Sehgal S
    BMJ Case Rep; 2020 May; 13(5):. PubMed ID: 32430353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WISP3 mutational analysis in Indian patients diagnosed with progressive pseudorheumatoid dysplasia and report of a novel mutation at p.Y198.
    Madhuri V; Santhanam M; Rajagopal K; Sugumar LK; Balaji V
    Bone Joint Res; 2016 Jul; 5(7):301-6. PubMed ID: 27436824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCN6 mutation detection in Chinese patients with progressive pseudo-rheumatoid dysplasia and identification of four novel mutations.
    Wang Y; Xiao K; Yang Y; Wu Z; Jin J; Qiu G; Weng X; Zhao X
    Mol Genet Genomic Med; 2020 Jul; 8(7):e1261. PubMed ID: 32351055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular study of WISP3 in nine families originating from the Middle-East and presenting with progressive pseudorheumatoid dysplasia: identification of two novel mutations, and description of a founder effect.
    Delague V; Chouery E; Corbani S; Ghanem I; Aamar S; Fischer J; Levy-Lahad E; Urtizberea JA; Mégarbané A
    Am J Med Genet A; 2005 Oct; 138A(2):118-26. PubMed ID: 16152649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progressive pseudorheumatoid dysplasia misdiagnosed as juvenile idiopathic arthritis: a case report.
    Omar AA; Ahmed S; Rodrigues JC; Kayiza A; Owino L
    J Med Case Rep; 2021 Nov; 15(1):551. PubMed ID: 34749805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel
    Yan W; Dai J; Xu Z; Shi D; Chen D; Xu X; Song K; Yao Y; Li L; Ikegawa S; Teng H; Jiang Q
    Hum Genome Var; 2016; 3():16041. PubMed ID: 28018607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ilizarov technique in an adolescent patient with progressive pseudorheumatoid dysplasia: A case report.
    Xiao K; Li T; Jiang Y; Li Z; Zhu Q; Wu Z; Weng X
    Medicine (Baltimore); 2018 Aug; 97(31):e11375. PubMed ID: 30075503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. WISP3, the gene responsible for the human skeletal disease progressive pseudorheumatoid dysplasia, is not essential for skeletal function in mice.
    Kutz WE; Gong Y; Warman ML
    Mol Cell Biol; 2005 Jan; 25(1):414-21. PubMed ID: 15601861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The CCN family member Wisp3, mutant in progressive pseudorheumatoid dysplasia, modulates BMP and Wnt signaling.
    Nakamura Y; Weidinger G; Liang JO; Aquilina-Beck A; Tamai K; Moon RT; Warman ML
    J Clin Invest; 2007 Oct; 117(10):3075-86. PubMed ID: 17823661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Progressive pseudorheumatoid dysplasia misdiagnosed as ankylosing spondylitis: a case report].
    Liu R; Zhai JY; Liu XY; Yao ZQ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1112-1116. PubMed ID: 30562792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An argument for early genomic sequencing in atypical cases: a WISP3 variant leads to diagnosis of progressive pseudorheumatoid arthropathy of childhood.
    Cassa CA; Smith SE; Docken W; Hoffman E; McLaughlin H; Chun S; Leshchiner I; Miraoui H; Raychaudhuri S; Frank NY; Wilson BJ; Sunyaev SR; Maas RL; ; Vuzman D
    Rheumatology (Oxford); 2016 Mar; 55(3):586-9. PubMed ID: 26493744
    [No Abstract]   [Full Text] [Related]  

  • 35. Unique mutation spectrum of progressive pseudorheumatoid dysplasia in the Chinese population: a retrospective genotype-phenotype analysis of 105 patients.
    Wang W; Gao SH; Wei M; Zhong LQ; Liu W; Jian S; Xiao J; Zhang CH; Zhang JG; Zeng XF; Xia WB; Qiu ZQ; Song HM
    World J Pediatr; 2023 Jul; 19(7):674-686. PubMed ID: 36622578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A homozygous deletion of exon 1 in WISP3 causes progressive pseudorheumatoid dysplasia in two siblings.
    Neerinckx B; Thues C; Wouters C; Lechner S; Westhovens R; Van Esch H
    Hum Genome Var; 2015; 2():15049. PubMed ID: 27081554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Rare Skeletal Dysplasia-Close Mimicker Of Juvenile Idiopathic Arthritis-Progressive Pseudorheumatoid Dysplasia.
    Riaz M; Khoso Z; Rai VR; Hanif MI; Ibrahim MN; Raza SJ
    J Ayub Med Coll Abbottabad; 2022; 34(Suppl 1)(4):S1050-S1052. PubMed ID: 36550675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia.
    Hurvitz JR; Suwairi WM; Van Hul W; El-Shanti H; Superti-Furga A; Roudier J; Holderbaum D; Pauli RM; Herd JK; Van Hul EV; Rezai-Delui H; Legius E; Le Merrer M; Al-Alami J; Bahabri SA; Warman ML
    Nat Genet; 1999 Sep; 23(1):94-8. PubMed ID: 10471507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progressive Pseudorheumatoid Dysplasia With Delayed Diagnosis.
    Yildizgoren MT; Sahin A; Osmanoglu K; Turhanoglu AD
    J Clin Rheumatol; 2015 Sep; 21(6):329. PubMed ID: 26274347
    [No Abstract]   [Full Text] [Related]  

  • 40. Specific early signs and long-term follow-up findings of progressive pseudorheumatoid dysplasia (PPRD) in the Turkish cohort.
    Uludağ Alkaya D; Kasapçopur Ö; Bursalı A; Adrovic A; Demir B; Aykut A; Tüysüz B
    Rheumatology (Oxford); 2022 Aug; 61(9):3693-3703. PubMed ID: 34919662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.